Health Care & Life Sciences » Pharmaceuticals | Shandong Wohua Pharmaceutical Co. Ltd.

Shandong Wohua Pharmaceutical Co. Ltd. | Income Statement

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
250,653.50
309,052.80
460,895.50
550,562.30
710,641.50
759,091.40
Cost of Goods Sold (COGS) incl. D&A
55,522.40
89,939.60
140,098.10
150,174.70
164,486.60
182,486.60
Gross Income
195,131.10
219,113.20
320,797.40
400,387.60
546,155.00
576,604.80
SG&A Expense
188,560.50
189,043.10
236,356.70
328,090.70
430,712.20
526,875.70
EBIT
6,365.90
27,614.20
80,489.90
73,597.60
115,161.90
48,110.80
Unusual Expense
-
-
-
-
17,357.20
6,668.50
Non Operating Income/Expense
6,267.00
7,609.70
1,889.30
10,172.60
8,907.10
2,094.60
Interest Expense
-
-
8,799.20
-
-
-
Pretax Income
10,624.30
36,549.20
85,487.90
70,131.30
91,697.50
43,600.70
Income Tax
3.00
1.20
3,559.50
8,677.40
10,899.60
3,604.80
Consolidated Net Income
10,621.30
36,548.00
81,928.40
61,453.90
80,797.90
39,996
Net Income
10,621.30
36,548.00
71,365.70
48,809.40
57,031.90
45,651.50
Net Income After Extraordinaries
10,621.30
36,548.00
71,365.70
48,809.40
57,031.90
45,651.50
Net Income Available to Common
10,621.30
36,548.00
71,365.70
48,809.40
57,031.90
45,651.50
EPS (Basic)
0.03
0.10
0.20
0.14
0.16
0.13
Basic Shares Outstanding
360,756.00
360,756.00
360,756.00
360,756.00
360,756.00
360,756
EPS (Diluted)
0.03
0.10
0.20
0.14
0.16
0.13
Diluted Shares Outstanding
360,756.00
360,756.00
360,756.00
360,756.00
360,756.00
360,756
EBITDA
20,991.60
42,280.00
102,219.90
92,638.40
135,459.80
67,009.50
Other Operating Expense
204.80
2,455.90
3,950.80
1,300.70
280.90
1,618.40
Non-Operating Interest Income
8,923.90
8,617.90
6,524.40
5,785.30
2,799.90
4,253.10
Minority Interest Expense
-
-
10,562.70
12,644.50
23,766.10
5,655.50

About Shandong Wohua Pharmaceutical Co.

View Profile
Address
No. 3517 Liyuan Street
Weifang Shandong 261205
China
Employees -
Website http://www.wohua.cn
Updated 07/08/2019
Shandong Wohua Pharmaceutical Co., Ltd. engages in the manufacture and sale of cardiovascular and cerebrovascular Chinese medicines. Its products include tablets and herbal medicines for respiratory, women and children, urinary system, body heat clearing, digestive system, and anti rheumatism. The company was founded on March 25, 2003 and is headquartered in Weifang, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.